Ipsos America, Inc.

Norwalk, CT Professional servicesNAICS 541910

Self-funded health planPlan year 2025Renews January
2,026Participants-2% vs. prior year
$4.8MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#2 of 8Professional services in CTBy participants

Overview

Ipsos America, Inc. sponsors a self-funded health plan that covered 2,026 participants in plan year 2025, down 3% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
2,026 · prior year 2,079
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Ipsos America Inc. Welfare Benefits Plan, plan 501 (2,026 participants)
Stop-loss carrier
Aetna Life Insurance Company
Broker compensation
$139K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilityDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Aetna Life Insurance CompanyStop-loss1,431$2.0M—
New York Life (life Insurance Company of North America)Accidental Death and Dismemberment, Long-term disability, Life, Short-term disability1,865$1.9M$74K
Delta Dental of New Jersey, Inc.Dental1,439$1.2M$35K
Eyemed Vision CareVision1,194$176K$15K
Metropolitan General Insurance Company (metlife Legal)Legal202$47K$7K
Unum Life Insurance Company of AmericaAccident, Critical Illness, Long Term Care97$41K$8K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$4.8M/ year

Estimated prescription spend: 2,026 participants × $2,371 national average per member. Usually higher once dependents are counted.

$125K–$308K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$37K–$91K
Lower-cost therapeutic alternatives$53K–$111K
Generic pricing vs. actual cost$23K–$69K
PBM contract terms$12K–$36K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Ipsos America, Inc.
Sponsor EIN
52-2073631
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 52-2073631 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Ipsos America, Inc. 401(k) Plan
Type
401(k) plan
Participants
2,926

About this data

Source: Ipsos America, Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Ipsos America, Inc..

Request a correction · Methodology